ATE65404T1 - COMPOSITIONS AND USE OF INTERLEUKIN-2 AND/OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE MANUFACTURE OF PHARMACEUTICALS OR FORMULATIONS. - Google Patents

COMPOSITIONS AND USE OF INTERLEUKIN-2 AND/OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE MANUFACTURE OF PHARMACEUTICALS OR FORMULATIONS.

Info

Publication number
ATE65404T1
ATE65404T1 AT87303120T AT87303120T ATE65404T1 AT E65404 T1 ATE65404 T1 AT E65404T1 AT 87303120 T AT87303120 T AT 87303120T AT 87303120 T AT87303120 T AT 87303120T AT E65404 T1 ATE65404 T1 AT E65404T1
Authority
AT
Austria
Prior art keywords
interleukin
interferon
pharmaceuticals
formulations
beta
Prior art date
Application number
AT87303120T
Other languages
German (de)
Inventor
Jeffrey Lee Winkelhake
Robert Zimmerman
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Priority claimed from EP87303120A external-priority patent/EP0248516B1/en
Application granted granted Critical
Publication of ATE65404T1 publication Critical patent/ATE65404T1/en

Links

AT87303120T 1986-04-09 1987-04-09 COMPOSITIONS AND USE OF INTERLEUKIN-2 AND/OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE MANUFACTURE OF PHARMACEUTICALS OR FORMULATIONS. ATE65404T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84971386A 1986-04-09 1986-04-09
US88454886A 1986-07-11 1986-07-11
US94360886A 1986-12-18 1986-12-18
EP87303120A EP0248516B1 (en) 1986-04-09 1987-04-09 Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations

Publications (1)

Publication Number Publication Date
ATE65404T1 true ATE65404T1 (en) 1991-08-15

Family

ID=27441272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87303120T ATE65404T1 (en) 1986-04-09 1987-04-09 COMPOSITIONS AND USE OF INTERLEUKIN-2 AND/OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE MANUFACTURE OF PHARMACEUTICALS OR FORMULATIONS.

Country Status (1)

Country Link
AT (1) ATE65404T1 (en)

Similar Documents

Publication Publication Date Title
DE3860043D1 (en) USE OF TREATMENT EXTRACT FOR THE PRODUCTION OF MEDICAL AND COSMETIC PREPARATIONS.
ATE79763T1 (en) USE OF AT LEAST ONE CYTOKINE IN THE MANUFACTURE OF A MEDICATION FOR THE SYSTEMIC TREATMENT OF PRAENEOPLASTIC LESIONS.
DE3579113D1 (en) COMPOSITIONS FOR THE REDUCTION, TREATMENT AND DETERMINATION OF ARTHRIC DISEASES AND SIMILAR CONDITIONS.
DE3583392D1 (en) AGENT CONTAINING CARBONATAPATITE AND THE USE OF CARBONATAPATITE FOR IMPLANTS.
DE69107946D1 (en) Adhesive preparation for promoting the regeneration of injured nerves and adhesive pharmaceutical preparations therefor.
ATE227587T1 (en) COMBINED USE OF HYALURONIC ACID AND THERAPEUTIC ACTIVE INGREDIENTS TO IMPROVE THE THERAPEUTIC EFFECT
DE19975063I1 (en) DNA encoding the human tumor necrosis factor and the human tumor neon rfactor polypeptide.
DE68913739D1 (en) COSMETIC AND SKIN TREATMENT COMPOSITIONS.
DE3771584D1 (en) COMPOSITIONS AND USE OF INTERLEUKIN-2 AND / OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE PRODUCTION OF MEDICINAL PRODUCTS OR FORMULATIONS.
DE3682882D1 (en) HUMAN IMMUNOGLOBULIN-G-FC-REGION-PROTEIN AND THEIR PRODUCTION.
DE3789530D1 (en) Cloning and expression of the acidic fibroblast growth factor.
DE3582594D1 (en) PROGLUMID AND ITS PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF NEOPLASTIC AFFECTIONS.
ATE74487T1 (en) PROCESSES FOR THE PREPARATION AND USE OF SOLID, PLANT-ACTIVE COMPOSITIONS.
IT8419681A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES AND LIVER DISEASES AND DYSFUNCTIONS.
DE3773387D1 (en) COMBINATION OF GAMMA INTERFERON AND ANTI-IGNITING AGENTS OR ANTIPYRETIC AGENTS FOR THE TREATMENT OF DISEASES.
IT1240683B (en) PHARMACEUTICAL COMPOSITION CONTAINING EGF
DE3679781D1 (en) USE OF COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF EPITHELIAL DESTRUCTION.
DE69104961D1 (en) Use of thiazolylalkoxyacrylates in the manufacture of insecticides and / or acanicide compositions.
DE3863200D1 (en) COMPOSITION TO BE USED IN CANCER THERAPY ON THE BASIS OF AMINO ACIDS AND VITAMINS.
ATE45675T1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) IN THE MANUFACTURE OF PREPARATIONS FOR THE TREATMENT OF RHEUMATIC DISEASES.
DE68900926D1 (en) PHARMACEUTICAL PREPARATION CONTAINING ZIDOVUDINE AND INOSIPLEX, OR INGREDIENTS THEREOF, FOR THE TREATMENT OF AIDS-RELATED SYNDROME.
DE68908404D1 (en) LONG-LASTING COMPOSITION OF PROPAFENONE AND CHINIDINE FOR TREATING THE STATE OF THE HEART.
DE3777359D1 (en) AMINO ACID SEQUENCE OF THE HUMAN ALPHA 2 PLASMIN INHIBITOR AND CDNS, AND GENOIC DNA CODING THIS AMINO ACID SEQUENCE.
DK193586D0 (en) N, N, N-TRIMETHYL-2-HYDROXYETHYL-AMMONIUM- (1-ETHYL-6-FLUOR-4-OXO-7- (1-PIPERAZINYL)) - 1,4-DIHYDRO-QUINOLIN-3-CARBOXYLATE, THE PREPARATION AND APPLICATION FOR HUMAN OR VETERINARY THERAPY
NO871107D0 (en) COMBINATION THERAPY USING INTERLEUKIN-2 AND / OR INTERFERON-BETA AND TUMOR NECROSIS FACTOR.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties